Skip to main content
Loading

CMC Analytical Considerations and Challenges for Oligonucleotides and Oligonucleotide-conjugates

30 Apr 2026
Oligonucleotides CMC
  • Analytical techniques, considerations and gaps supporting oligonucleotide and oligonucleotide-conjugate drug development
  • Method development, validation & transfer challenges
  • Impurity identification and characterization for complex modalities
Industry Expert
Hongling Han, , Senior Director, Head of Analytical Development and QC - PepGen